MEDI Harbor Health Care ETF

ETF

ETF quote, holdings, sector allocation, technicals, and options analytics. Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

MEDI — —
Key stats
About

Harbor Health Care ETF (MEDI) ETF

No description available.

Exchange
ARCX
Inception
2022-11-16
Has Options
No
Fund profile
holdings as of Jul 31, 2026SEC filingthrough Jul 2026flows, SEC filings
Sector Health Care#20 of 29 by assets Harbor US Actively managed
Expense ratio
0.80%
prospectus, filed Feb 27, 2026
Assets
$43M
shares × price, Oct 23, 2026
Trailing yield
0.22%
paid annual
Average daily volume
$165K
30 sessions
Holdings
44
top 10 are 59.7%
Listed
Nov 16, 2022
NYSE Arca
Closure risk, 12 months
4.7%
low: trading volume · model
FrenzyCap ETF score
14
how it is built
Cost5
Liquidity7
Scale23
Diversification32

Moves with. US large-cap stocks (11% of its variance, beta 0.56); Small caps over large (7% of its variance, beta 0.40); Developed markets ex-US over US (4% of its variance, beta 0.38); Long Treasuries (4% of its variance, beta 0.28). These factors explain 28% of its daily moves over the last year, so most of what drives this fund is something else.

Stated objective. The Fund seeks long-term growth of capital. (from the fund's prospectus)

All 44 holdingsFlow historySimilar fundsOverlap toolAll Health Care ETFs

Fund flows
through Jul 2026SEC filings
Jul 2026
$0
latest reported month
Latest 3 months
+$11M
+25.7% of assets
Latest 12 months
+$20M
+47.8% of assets
Aug 2025: +$2.1MSep 2025: $0SepOct 2025: $0Nov 2025: +$1.5MNovDec 2025: +$2.4MJan 2026: +$799KJanFeb 2026: +$2.4MMar 2026: $0MarApr 2026: $0May 2026: +$8.3M+$8.3MMayJun 2026: +$2.3MJul 2026: $0Jul
View as a table
Net flows of MEDI by month, Aug 2025 to Jul 2026
MonthNet flow
Jul 2026$0
Jun 2026+$2.3M
May 2026+$8.3M
Apr 2026$0
Mar 2026$0
Feb 2026+$2.4M
Jan 2026+$799K
Dec 2025+$2.4M
Nov 2025+$1.5M
Oct 2025$0
Sep 2025$0
Aug 2025+$2.1M

Net creations and redemptions from the fund's SEC filings, which become public about 60 days after each quarter. Every month since 45 months ago

Similar funds
FundOverlapFeeAssets1Y
TMEDT. Rowe Price Health Care ETF42%0.44%$23M+19.6%compare
GDOCGoldman Sachs Future Health Care Equity ETF40%0.75%$20M+10.2%compare
HRTSTema ETF Trust Tema Heart & Health ETF38%0.75%$55M+15.5%compare
TRUHVanEck Healthcare TruSector ETF38%—$833K—compare
XLVState Street Health Care Select Sector SPDR ETF38%0.08%$47.7B+22.8%compare

Ranked by how much of the two portfolios is the same securities.

Look-through: what the holdings say
weights as of Jul 31, 2026SEC filing
Holdings vs fair value
+1.8%
23% under, 17% over · 86% covered
Price / earnings
220.5
37% loss-making · 78% covered
Price / book · sales
10.3 · 2.3
revenue growth +13.6%
Above 200-day average
70%
63% above 50-day · by weight
Short interest
4.7%
of float, weighted · 4.6 days to cover
Insider buying
6%
of weight had net insider buying, 90 days; 62% net selling
13F holders
+2.5%
change in shares held by institutions, latest quarter
Reporting earnings
44.0%
of weight in 7 days; 71.2% in 14
Largest contributors below fair value
COR+50%PCVX+50%MCK+50%BSX+17%RDNT+50%
Largest contributors above fair value
GILD−19%LLY−4%ISRG−30%NTRA−30%DHR−20%

Each figure is the fund's holdings weighted by position size, using our data on those stocks, and covers only the share of the stock holdings stated. Positive fair value means the holdings trade below our estimate.

What changed in the portfolio
Apr 30, 2026 → Jul 31, 2026
ActionHoldingWeight beforeWeight afterShares vs flows
New positionGILDGilead Sciences Inc—5.10%—
DecreaseLEGNLegend Biotech Corp5.13%1.91%−42.7%
DecreasePCVXVaxcyte Inc4.64%2.06%−42.9%
ExitWGSGeneDx Holdings Corp2.12%——
New positionARGXArgenx SE—2.07%—
New positionMCKMcKesson Corp—2.02%—
DecreaseABBVAbbVie Inc4.78%3.09%−33.8%
IncreasePODDInsulet Corp0.57%2.10%+365.5%
DecreaseABVXAbivax SA3.54%2.16%−30.1%
New positionPTCTPTC Therapeutics Inc—1.31%—

10 new, 6 exited, 15 increased and 11 decreased between the fund's two latest holdings reports; turnover 21.2%. Full holdings and history

Under the hood
fiscal year to Oct 31, 2025SEC census
Authorized participants
4 active
of 15 with agreements; top 3 did 90%
Created · redeemed
$3.4M · $3.3M
over the fiscal year
Redemptions in kind
98%
creations 99% in kind
Creation unit
25,000
shares
Securities lending
authorized, none lent
Diversification status
Non-diversified
may concentrate in fewer issuers

From the fund's annual census filing with the SEC. In-kind redemptions are what let an ETF shed appreciated securities without realising gains.

ETF Profile
holdings as of 2026-07-31
Holdings
44
AUM
$41.0M
Provider
Nport
Inception
2022-11-16
Exchange
ARCX
Data As Of
2026-07-31
Expense Ratio
0.80%
Dividend Yield
0.22%
Distribution
Annual
Recent distributions
Ex-Date Pay Date Amount Type
2025-12-19 2025-12-24 $0.0751 CD
2024-12-20 2024-12-26 $0.1346 CD
2023-12-21 2023-12-27 $0.4613 CD
Asset Allocation
Top Holdings
top 44 of 44 holdings
Symbol Name Weight % Asset Class Country
LLY Eli Lilly & Co 20.78% Equity (common) US
— Ascendis Pharma A/S 13.61% Equity (common) DK
GILD Gilead Sciences Inc 5.10% Equity (common) US
RYTM Rhythm Pharmaceuticals Inc 4.02% Equity (common) US
ABBV AbbVie Inc 3.09% Equity (common) US
ISRG Intuitive Surgical Inc 2.83% Equity (common) US
COR Cencora Inc 2.75% Equity (common) US
RVMD Revolution Medicines Inc 2.54% Equity (common) US
INSM Insmed Inc 2.52% Equity (common) US
MRK Merck & Co Inc 2.47% Equity (common) US
BSX Boston Scientific Corp 2.40% Equity (common) US
NTRA Natera Inc 2.26% Equity (common) US
ABVX Abivax SA 2.16% Equity (common) FR
PODD Insulet Corp 2.10% Equity (common) US
ARGX Argenx SE 2.07% Equity (common) NL
PCVX Vaxcyte Inc 2.06% Equity (common) US
MCK McKesson Corp 2.02% Equity (common) US
LEGN Legend Biotech Corp 1.91% Equity (common) KY
DHR Danaher Corp 1.73% Equity (common) US
GH Guardant Health Inc 1.54% Equity (common) US
NVO Novo Nordisk A/S 1.46% Equity (common) DK
IDXX IDEXX Laboratories Inc 1.40% Equity (common) US
UNH UnitedHealth Group Inc 1.39% Equity (common) US
PTCT PTC Therapeutics Inc 1.31% Equity (common) US
VRTX Vertex Pharmaceuticals Inc 1.22% Equity (common) US
ALNY Alnylam Pharmaceuticals Inc 1.21% Equity (common) US
TMO Thermo Fisher Scientific Inc 1.16% Equity (common) US
ADPT Adaptive Biotechnologies Corp 0.98% Equity (common) US
MDGL Madrigal Pharmaceuticals Inc 0.93% Equity (common) US
PRAX Praxis Precision Medicines Inc 0.91% Equity (common) US
DXCM Dexcom Inc 0.81% Equity (common) US
RDNT RadNet Inc 0.80% Equity (common) US
PEN Penumbra Inc 0.77% Equity (common) US
RLAY Relay Therapeutics Inc 0.64% Equity (common) US
ORKA Oruka Therapeutics Inc 0.60% Equity (common) US
IRTC IRhythm Holdings Inc 0.58% Equity (common) US
VTRS Viatris Inc 0.57% Equity (common) US
— Newamsterdam Pharma Co NV 0.52% Equity (common) NL
XENE Xenon Pharmaceuticals Inc 0.51% Equity (common) CA
INDV Indivior Pharmaceuticals Inc 0.50% Equity (common) US
AXSM Axsome Therapeutics Inc 0.49% Equity (common) US
IVA Inventiva SACA 0.37% Equity (common) FR
— Sophia Genetics SA 0.33% Equity (common) CH
IONS Ionis Pharmaceuticals Inc 0.20% Equity (common) US
Geographic Breakdown
Chart
Seasonality
'22'23'24'25'26Avg
Jan--2.79%-1.38%6.74%-0.25%1.98%
Feb---2.26%5.22%2.13%0.88%1.49%
Mar--0.66%0.35%-3.38%-6.98%-2.34%
Apr--3.45%-6.30%6.39%0.27%0.95%
May---1.33%-1.61%-2.54%3.88%-0.40%
Jun--4.75%1.23%4.35%11.86%5.55%
Jul--0.80%5.99%-0.06%-4.59%0.54%
Aug--0.17%1.98%3.57%6.07%2.95%
Sep---1.65%1.02%2.54%-4.34%-0.61%
Oct---3.03%-4.41%2.77%3.82%*-0.21%
Nov5.45%6.99%0.91%9.08%--5.61%
Dec-3.03%6.52%-7.61%-2.14%---1.57%
Total2.25%18.67%-5.43%32.69%9.61%11.56%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $32.74
SMA 50: $33.43
SMA 200: $31.85
Current: $33.70
EMA 12: $33.14
EMA 26: $33.03
MACD: 0.1048 | Signal: 0.2031
BEARISH
ADX (14): 20.32
WEAK TREND
+DI: 34.90
−DI: 30.23

Momentum Oscillators

RSI (14): 57.40
NEUTRAL
Stoch %K: 93.46
Stoch %D: 93.51
Williams %R: -6.67

Volume & Volatility

BB Upper: $33.90
BB Lower: $31.59
NEUTRAL
OBV: 210,932
Vol SMA 20: 4,318
Vol ROC: -82.71%
ATR: $0.47
True Range: $0.19
HV 20: 20.4%
HV 30: 20.4%
HV 60: 19.6%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
All MEDI news →

MEDI Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 0.5062
Alpha: 7.65%
Correlation: 0.3119
R-Squared: 9.7%
Stock Volatility: 20.7%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time

MEDI Institutional Ownership (13F)

Latest filings — 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

12 filers814,271 shares$27.32M value
# Filer Shares Value % of Total % of Float Period
1 LPL Financial LLC Custodian 235,929 $7.98M 29.22% — 2026-06-30
2 Pinnacle Financial Partners, Inc. 216,677 $7.33M 26.84% — 2026-06-30
3 COMMONWEALTH EQUITY SERVICES, LLC 209,783 $7.10M 25.98% — 2026-06-30
4 SYNOVUS FINANCIAL CORP 44,036 $1.26M 4.60% — 2025-09-30
5 TRUIST FINANCIAL CORP Custodian 27,339 $925.15K 3.39% — 2026-06-30
6 OSAIC HOLDINGS, INC. Custodian 21,978 $743.74K 2.72% — 2026-06-30
7 Citadel Advisors LLC Custodian 20,947 $708.85K 2.59% — 2026-06-30
8 GTS SECURITIES LLC 18,065 $611.32K 2.24% — 2026-06-30
9 Susquehanna International Group, LLP Custodian 11,187 $378.57K 1.39% — 2026-06-30
10 Private Advisor Group, LLC 7,500 $253.80K 0.93% — 2026-06-30
11 PRIVATE TRUST CO NA 500 $16.37K 0.06% — 2026-09-30
12 Steward Partners Investment Advisory, LLC 330 $11.17K 0.04% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
MEDI Constituent Performance

Click any bar to view the full quote for that stock.

MEDI Constituents (41 of 41)
Symbol Name Weight % Price 1 Day 1 Week 1 Month
LLY Eli Lilly & Co 20.78% $1279.14 +0.45%+3.13%+7.96%
GILD Gilead Sciences Inc 5.10% $158.69 +1.70%+3.67%+4.26%
RYTM Rhythm Pharmaceuticals Inc 4.02% $89.47 +0.22%+1.41%-9.22%
ABBV AbbVie Inc 3.09% $286.74 +0.39%+1.44%+7.68%
ISRG Intuitive Surgical Inc 2.83% $451.63 -0.15%+4.26%+8.88%
COR Cencora Inc 2.75% $330 -0.30%-2.94%+8.62%
RVMD Revolution Medicines Inc 2.54% $183.9 -1.65%+0.96%-8.84%
INSM Insmed Inc 2.52% $93.33 -0.06%-2.06%-20.68%
MRK Merck & Co Inc 2.47% $140.61 -3.21%-2.10%-5.43%
BSX Boston Scientific Corp 2.40% $45.58 -0.24%+1.18%+3.33%
NTRA Natera Inc 2.26% $404.9 +0.24%+1.37%-1.67%
ABVX Abivax SA 2.16% $86.5 -1.72%-1.13%-10.69%
PODD Insulet Corp 2.10% $149.26 +0.17%+5.14%+12.13%
ARGX Argenx SE 2.07% $869.33 -0.50%+5.30%-10.59%
PCVX Vaxcyte Inc 2.06% $59.97 -0.76%-5.83%+2.92%
MCK McKesson Corp 2.02% $992.87 -0.79%-1.74%+15.95%
LEGN Legend Biotech Corp 1.91% $20.39 +5.81%+9.33%+9.51%
DHR Danaher Corp 1.73% $232.97 +1.07%+3.81%+2.48%
GH Guardant Health Inc 1.54% $173.25 +2.47%+9.74%-2.30%
NVO Novo Nordisk A/S 1.46% $39.13 +0.20%+1.85%+1.08%
IDXX IDEXX Laboratories Inc 1.40% $570.21 +1.75%+2.59%+7.78%
UNH UnitedHealth Group Inc 1.39% $410.7 -1.77%+0.94%+8.70%
PTCT PTC Therapeutics Inc 1.31% $61.07 +0.79%-0.75%-7.40%
VRTX Vertex Pharmaceuticals Inc 1.22% $517.49 -1.23%+3.10%-1.93%
ALNY Alnylam Pharmaceuticals Inc 1.21% $227.66 +1.62%-2.41%-10.85%
TMO Thermo Fisher Scientific Inc 1.16% $684.89 +1.64%+0.81%+0.93%
ADPT Adaptive Biotechnologies Corp 0.98% $26.27 +2.98%+9.69%-7.86%
MDGL Madrigal Pharmaceuticals Inc 0.93% $437.74 +0.81%-2.09%-15.34%
PRAX Praxis Precision Medicines Inc 0.91% $267.39 +5.70%+2.78%-6.39%
DXCM Dexcom Inc 0.81% $78.57 +0.81%-8.62%-9.36%
RDNT RadNet Inc 0.80% $70.05 -0.41%+1.13%-2.45%
PEN Penumbra Inc 0.77% $325.22 +0.26%+0.87%+1.89%
RLAY Relay Therapeutics Inc 0.64% $18.12 -0.33%+6.03%+2.43%
ORKA Oruka Therapeutics Inc 0.60% $90.33 +12.70%+21.28%+7.29%
IRTC IRhythm Holdings Inc 0.58% $121.93 +0.54%+11.25%+8.29%
VTRS Viatris Inc 0.57% $18.29 +1.61%+0.16%+0.11%
XENE Xenon Pharmaceuticals Inc 0.51% $35.77 +1.22%+1.97%-2.59%
INDV Indivior Pharmaceuticals Inc 0.50% $34.56 +0.26%+2.04%-6.29%
AXSM Axsome Therapeutics Inc 0.49% $144.06 -0.68%-7.54%-25.70%
IVA Inventiva SACA 0.37% $3.66 -1.35%+22.82%+3.68%
IONS Ionis Pharmaceuticals Inc 0.20% $43.42 +1.14%-2.16%-4.72%